[HTML][HTML] Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach

TH Kim, IH Kim, SJ Kang, M Choi, BH Kim… - Journal of gastric …, 2023 - ncbi.nlm.nih.gov
Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this
is the 4th gastric cancer guideline published in Korea which is the revised version of …

Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives

M Tokunaga, Y Sato, M Nakagawa, T Aburatani… - Surgery today, 2020 - Springer
The standard treatment for locally advanced gastric cancer differs across the world. In
western countries, perioperative chemotherapy or postoperative adjuvant …

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

FH Wang, XT Zhang, YF Li, L Tang, XJ Qu… - Cancer …, 2021 - Wiley Online Library
There exist differences in the epidemiological characteristics, clinicopathological features,
tumor biological characteristics, treatment patterns, and drug selections between gastric …

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

FH Wang, L Shen, J Li, ZW Zhou, H Liang… - Cancer …, 2019 - Springer
China is one of the countries with the highest incidence of gastric cancer. There are
differences in epidemiological characteristics, clinicopathological features, tumor biological …

The long-term survival of stage IV gastric cancer patients with conversion therapy

K Yamaguchi, K Yoshida, T Tanahashi, T Takahashi… - Gastric Cancer, 2018 - Springer
Purpose A retrospective study was performed to clarify the role of conversion therapy
(surgery with a prospect of R0 resection performed in initially unresectable metastatic cancer …

International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO‐GC‐1)

K Yoshida, I Yasufuku, M Terashima… - Annals of …, 2022 - Wiley Online Library
Aim Much attention has been paid to conversion therapy for stage IV gastric cancer,
however, its operative comorbidities and survival benefit have not yet been clarified. CONVO …

lncRNA GAS5‐promoted apoptosis in triple‐negative breast cancer by targeting miR‐378a‐5p/SUFU signaling

S Zheng, M Li, K Miao, H Xu - Journal of cellular biochemistry, 2020 - Wiley Online Library
Abstract Purpose Long‐chain noncoding RNAs (lncRNAs) are involved in regulating the
sensitivity of cancer cells to chemotherapeutic drugs, but the specific mechanism of action is …

A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A)

T Fukagawa, H Katai, J Mizusawa, K Nakamura… - Gastric Cancer, 2018 - Springer
Background Neoadjuvant chemotherapy (NAC) followed by radical surgery is a promising
strategy to improve survival of patients with stage III gastric cancer, but is associated with the …

Extended lymphadenectomy for gastric cancer in the neoadjuvant era: current status, clinical implications and contentious issues

L Marano, L Carbone, GE Poto, V Restaino… - Current …, 2023 - mdpi.com
Despite its decreasing incidence, gastric cancer remains an important global healthcare
problem due to its overall high prevalence and high mortality rate. Since the MAGIC and …

Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical …

M Terashima, Y Iwasaki, J Mizusawa, H Katayama… - Gastric Cancer, 2019 - Springer
Background The prognosis of patients with linitis plastica (type 4) and large (≥ 8 cm) ulcero-
invasive-type (type 3) gastric cancer is extremely poor, even after extended surgery and …